Marnix Van Loock

2.0k total citations
43 papers, 1.1k citations indexed

About

Marnix Van Loock is a scholar working on Infectious Diseases, Microbiology and Epidemiology. According to data from OpenAlex, Marnix Van Loock has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 15 papers in Microbiology and 14 papers in Epidemiology. Recurrent topics in Marnix Van Loock's work include Reproductive tract infections research (15 papers), Herpesvirus Infections and Treatments (10 papers) and Mosquito-borne diseases and control (9 papers). Marnix Van Loock is often cited by papers focused on Reproductive tract infections research (15 papers), Herpesvirus Infections and Treatments (10 papers) and Mosquito-borne diseases and control (9 papers). Marnix Van Loock collaborates with scholars based in Belgium, United States and United Kingdom. Marnix Van Loock's co-authors include Ellen Van Damme, Daisy Vanrompay, Bruno Goddeeris, Tom Geens, Kristel Verminnen, Karin D. E. Everett, Kim Thys, Christophe Buyck, Sandra De Meyer and Jindřich Činátl and has published in prestigious journals such as Nature Communications, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Marnix Van Loock

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marnix Van Loock Belgium	19	457	379	356	178	144	43	1.1k
Maria Leonor S. Oliveira Brazil	24	756 1.7×	456 1.2×	247 0.7×	288 1.6×	127 0.9×	67	1.5k
Yuko Sasaki Japan	19	772 1.7×	793 2.1×	127 0.4×	336 1.9×	101 0.7×	45	1.6k
Jenni M. Vuola Finland	15	457 1.0×	125 0.3×	424 1.2×	248 1.4×	269 1.9×	25	1.1k
Tsuguo Sasaki Japan	19	781 1.7×	799 2.1×	170 0.5×	188 1.1×	78 0.5×	48	1.4k
Yoichiro Kino Japan	17	479 1.0×	74 0.2×	285 0.8×	115 0.6×	121 0.8×	42	750
Simon G. P. Funnell United Kingdom	18	461 1.0×	352 0.9×	180 0.5×	245 1.4×	57 0.4×	37	825
Michael J. Parnell United States	18	436 1.0×	312 0.8×	521 1.5×	334 1.9×	404 2.8×	31	1.4k
Branda Hu United States	17	464 1.0×	154 0.4×	565 1.6×	168 0.9×	190 1.3×	33	1.1k
Runxia Liu United States	15	708 1.5×	86 0.2×	321 0.9×	198 1.1×	36 0.3×	25	1.1k
Gary S. Nabors United States	18	846 1.9×	393 1.0×	240 0.7×	222 1.2×	382 2.7×	22	1.4k

Countries citing papers authored by Marnix Van Loock

Since Specialization

Citations

This map shows the geographic impact of Marnix Van Loock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marnix Van Loock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marnix Van Loock more than expected).

Fields of papers citing papers by Marnix Van Loock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marnix Van Loock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marnix Van Loock. The network helps show where Marnix Van Loock may publish in the future.

Co-authorship network of co-authors of Marnix Van Loock

This figure shows the co-authorship network connecting the top 25 collaborators of Marnix Van Loock. A scholar is included among the top collaborators of Marnix Van Loock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marnix Van Loock. Marnix Van Loock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kiemel, Dominik, Solène Denolly, Uta Haselmann, et al.. (2024). Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation. Nature Communications. 15(1). 6080–6080. 13 indexed citations

Doijen, Jordi, Inha Heo, Koen Temmerman, et al.. (2023). A flexible, image-based, high-throughput platform encompassing in-depth cell profiling to identify broad-spectrum coronavirus antivirals with limited off-target effects. Antiviral Research. 222. 105789–105789. 1 indexed citations

Chiu, Winston, Christel Van den Eynde, Christophe Buyck, et al.. (2022). Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures. Journal of Medical Virology. 94(7). 3101–3111. 12 indexed citations

Waickman, Adam T., Hengsheng Fang, Jeffrey R. Currier, et al.. (2022). Evolution of inflammation and immunity in a dengue virus 1 human infection model. Science Translational Medicine. 14(668). eabo5019–eabo5019. 23 indexed citations

Brady, Oliver J., Adam J. Kucharski, Sebastian Funk, et al.. (2021). Case-area targeted interventions (CATI) for reactive dengue control: Modelling effectiveness of vector control and prophylactic drugs in Singapore. PLoS neglected tropical diseases. 15(8). e0009562–e0009562. 3 indexed citations

Meyer, Sandra De, Denisa Bojková, Jindřich Činátl, et al.. (2020). Lack of antiviral activity of darunavir against SARS-CoV-2. International Journal of Infectious Diseases. 97. 7–10. 95 indexed citations

Loock, Marnix Van, et al.. (2018). An Industry Perspective on Dengue Drug Discovery and Development. Advances in experimental medicine and biology. 1062. 333–353. 8 indexed citations

Geluykens, Peggy, Olivia Goethals, Stefaan Last, et al.. (2017). Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library. Antiviral Research. 147. 149–158. 15 indexed citations

Sijmons, Steven, Kim Thys, Mirabeau Mbong Ngwese, et al.. (2015). High-Throughput Analysis of Human Cytomegalovirus Genome Diversity Highlights the Widespread Occurrence of Gene-Disrupting Mutations and Pervasive Recombination. Journal of Virology. 89(15). 7673–7695. 134 indexed citations

10.

Sijmons, Steven, Kim Thys, Ellen Van Damme, et al.. (2014). A Method Enabling High-Throughput Sequencing of Human Cytomegalovirus Complete Genomes from Clinical Isolates. PLoS ONE. 9(4). e95501–e95501. 23 indexed citations

11.

Loock, Marnix Van, et al.. (2013). An Automated Time-of-Drug-Addition Assay to Routinely Determine the Mode of Action of HIV-1 Inhibitors. Assay and Drug Development Technologies. 11(8). 489–500. 7 indexed citations

12.

Clayton, R., Åsa Öhagen, François Nicol, et al.. (2009). Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes. Antiviral Research. 84(2). 142–149. 32 indexed citations

13.

Verminnen, Kristel, Marnix Van Loock, Hafez Mohamed Hafez, et al.. (2006). Evaluation of a recombinant enzyme-linked immunosorbent assay for detectingChlamydophila psittaciantibodies in turkey sera. Veterinary Research. 37(4). 623–632. 36 indexed citations

14.

Clayton, R., Åsa Öhagen, Olivia Goethals, et al.. (2006). Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1κ monoclonal antibody, in HIV-1 infected cells. Journal of Virological Methods. 139(1). 17–23. 9 indexed citations

15.

Loock, Marnix Van, Kristel Verminnen, Trudy O. Messmer, et al.. (2005). Use of a nested PCR-enzyme immunoassay with an internal control to detect Chlamydophila psittaciin turkeys. BMC Infectious Diseases. 5(1). 76–76. 40 indexed citations

16.

Loock, Marnix Van, et al.. (2005). CpG motifs as adjuvant in DNA vaccination against Chlamydophila psittaci in turkeys. Vaccine. 24(21). 4598–4601. 15 indexed citations

17.

Verminnen, Kristel, Marnix Van Loock, Eric Cox, Bruno Goddeeris, & Daisy Vanrompay. (2005). Protection of turkeys against Chlamydophila psittaci challenge by DNA and rMOMP vaccination and evaluation of the immunomodulating effect of 1α,25-dihydroxyvitamin D3. Vaccine. 23(36). 4509–4516. 26 indexed citations

18.

Geens, Tom, Marnix Van Loock, E. F. Kaleta, et al.. (2004). Serological and molecular characterization of Chlamydophila psittaci strains using serovar-specific monoclonal antibodies, OmpA RFLP analysis and OmpA sequencing. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

19.

Verminnen, Kristel, Marnix Van Loock, Eric Cox, & Daisy Vanrompay. (2004). Protection of turkeys against Chlamydophila psittaci challenge by DNA and rMOMP vaccination and evaluation of the immunomodulating effect of 1 alpha,25-dihydroxyvitamin D-3. Ghent University Academic Bibliography (Ghent University). 2 indexed citations

20.

Vanrompay, Daisy, et al.. (2004). Immunoblotting, ELISA and culture evidence for Chlamydiaceae in sows on 258 Belgian farms. Veterinary Microbiology. 99(1). 59–66. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact